Some test frames for this alternate timeline TNBC promo I'm working on.
November 13, 2026 at 11:43 PM
Some test frames for this alternate timeline TNBC promo I'm working on.
"New School meets Old School, only on TNBC!"
November 14, 2026 at 1:27 AM
"New School meets Old School, only on TNBC!"
"Is it T for teens, or T for toons? Find out this Saturday on TNBC!"
November 14, 2026 at 1:22 AM
"Is it T for teens, or T for toons? Find out this Saturday on TNBC!"
Simple little Shock from Nightmare Before Christmas.
#art #artsky #drawing #ink #inks #metallic #posca #Drawtober #drawloween #shock #nightmarebeforechristmas #tnbc #witch #sketchbook
#art #artsky #drawing #ink #inks #metallic #posca #Drawtober #drawloween #shock #nightmarebeforechristmas #tnbc #witch #sketchbook
November 12, 2026 at 1:11 AM
Simple little Shock from Nightmare Before Christmas.
#art #artsky #drawing #ink #inks #metallic #posca #Drawtober #drawloween #shock #nightmarebeforechristmas #tnbc #witch #sketchbook
#art #artsky #drawing #ink #inks #metallic #posca #Drawtober #drawloween #shock #nightmarebeforechristmas #tnbc #witch #sketchbook
🎯 INSIDE THE TARGET | TROP-2
TROP-2 is a key ADC target in breast cancer, particularly TNBC. Sacituzumab govitecan and datopotamab deruxtecan have advanced its therapeutic potential, but ADC resistance and heterogeneous TROP-2 expression remain key challenges.
#TargetMol #TROP2 #ADC #TNBC
TROP-2 is a key ADC target in breast cancer, particularly TNBC. Sacituzumab govitecan and datopotamab deruxtecan have advanced its therapeutic potential, but ADC resistance and heterogeneous TROP-2 expression remain key challenges.
#TargetMol #TROP2 #ADC #TNBC
November 13, 2026 at 10:09 AM
🎯 INSIDE THE TARGET | TROP-2
TROP-2 is a key ADC target in breast cancer, particularly TNBC. Sacituzumab govitecan and datopotamab deruxtecan have advanced its therapeutic potential, but ADC resistance and heterogeneous TROP-2 expression remain key challenges.
#TargetMol #TROP2 #ADC #TNBC
TROP-2 is a key ADC target in breast cancer, particularly TNBC. Sacituzumab govitecan and datopotamab deruxtecan have advanced its therapeutic potential, but ADC resistance and heterogeneous TROP-2 expression remain key challenges.
#TargetMol #TROP2 #ADC #TNBC
Overcoming Trk inhibitor resistance in triple-negative #BreastCancer (#TNBC).
This study shows that targeting CD44v3 with a peptide improves Entrectinib response and reduces brain micrometastatic spread in a preclinical model. @univlille.bsky.social
#STTT #OpenAccess: doi.org/10.1038/s413...
This study shows that targeting CD44v3 with a peptide improves Entrectinib response and reduces brain micrometastatic spread in a preclinical model. @univlille.bsky.social
#STTT #OpenAccess: doi.org/10.1038/s413...
November 13, 2026 at 5:35 AM
Overcoming Trk inhibitor resistance in triple-negative #BreastCancer (#TNBC).
This study shows that targeting CD44v3 with a peptide improves Entrectinib response and reduces brain micrometastatic spread in a preclinical model. @univlille.bsky.social
#STTT #OpenAccess: doi.org/10.1038/s413...
This study shows that targeting CD44v3 with a peptide improves Entrectinib response and reduces brain micrometastatic spread in a preclinical model. @univlille.bsky.social
#STTT #OpenAccess: doi.org/10.1038/s413...
It's been a whole week since the #BlueWave™ and there've been ZERO announcements for TNBC DVDs or BDs ("Blu Wave?")! Like, what was even the point?
November 11, 2026 at 3:22 AM
It's been a whole week since the #BlueWave™ and there've been ZERO announcements for TNBC DVDs or BDs ("Blu Wave?")! Like, what was even the point?
my TNBC OC Olivella c: Jack and Sally's daughter. i still love her so much
forgive me, the left is the OLDEST art i can find of her and it's by DB-artwork on dA, circa 2009. but this character has been around for a few years before than that. dont ask me why she had human skin even i don't know
forgive me, the left is the OLDEST art i can find of her and it's by DB-artwork on dA, circa 2009. but this character has been around for a few years before than that. dont ask me why she had human skin even i don't know
November 10, 2026 at 7:51 PM
my TNBC OC Olivella c: Jack and Sally's daughter. i still love her so much
forgive me, the left is the OLDEST art i can find of her and it's by DB-artwork on dA, circa 2009. but this character has been around for a few years before than that. dont ask me why she had human skin even i don't know
forgive me, the left is the OLDEST art i can find of her and it's by DB-artwork on dA, circa 2009. but this character has been around for a few years before than that. dont ask me why she had human skin even i don't know
Triple-negative breast cancer thrives by rewiring its metabolism.
This study identifies LINC01357 as a driver of #TNBC progression, promoting #FattyAcidMetabolism through the MYH9/Notch pathway and highlighting a promising #biomarker.
#GenesAndDiseases: doi.org/10.1016/j.ge...
This study identifies LINC01357 as a driver of #TNBC progression, promoting #FattyAcidMetabolism through the MYH9/Notch pathway and highlighting a promising #biomarker.
#GenesAndDiseases: doi.org/10.1016/j.ge...
November 9, 2026 at 1:05 PM
Triple-negative breast cancer thrives by rewiring its metabolism.
This study identifies LINC01357 as a driver of #TNBC progression, promoting #FattyAcidMetabolism through the MYH9/Notch pathway and highlighting a promising #biomarker.
#GenesAndDiseases: doi.org/10.1016/j.ge...
This study identifies LINC01357 as a driver of #TNBC progression, promoting #FattyAcidMetabolism through the MYH9/Notch pathway and highlighting a promising #biomarker.
#GenesAndDiseases: doi.org/10.1016/j.ge...
Good luck to you Andrew. ❤️ actually it’s exactly one year since my wife got her TNBC diagnosis and I know for a fact what healthcare can do nowadays. Hopefully you can get through this without any major sickness and side effects. It’s tough, but I guess it’s part of the way we call life. ❤️❤️
November 14, 2026 at 8:45 AM
Good luck to you Andrew. ❤️ actually it’s exactly one year since my wife got her TNBC diagnosis and I know for a fact what healthcare can do nowadays. Hopefully you can get through this without any major sickness and side effects. It’s tough, but I guess it’s part of the way we call life. ❤️❤️
I'm of the age where I remember it during Saturday Morning, but I also abandoned cartoons for what was for me aspirational: TNBC. I have thoughts on California Dreams and Hang Time in addition to Saved by the Bell.
November 12, 2026 at 9:28 PM
I'm of the age where I remember it during Saturday Morning, but I also abandoned cartoons for what was for me aspirational: TNBC. I have thoughts on California Dreams and Hang Time in addition to Saved by the Bell.
WATCH 🎥: Kelsey Natsuhara, MD, of @ucsfcancer.bsky.social, discusses emerging ADCs and the importance of clinical trial enrollment in triple-negative breast cancer at the Bridging the Gaps in Breast Cancer meeting. #bcsm #oncology
Full video ➡️: www.onclive.com/view/dr-nats...
Full video ➡️: www.onclive.com/view/dr-nats...
Dr Natsuhara on Treatment Advances and Research Considerations in TNBC | OncLive
Kelsey H. Natsuhara, MD, discusses emerging ADCs and the importance of clinical trial enrollment in triple-negative breast cancer.
www.onclive.com
November 11, 2026 at 1:50 AM
WATCH 🎥: Kelsey Natsuhara, MD, of @ucsfcancer.bsky.social, discusses emerging ADCs and the importance of clinical trial enrollment in triple-negative breast cancer at the Bridging the Gaps in Breast Cancer meeting. #bcsm #oncology
Full video ➡️: www.onclive.com/view/dr-nats...
Full video ➡️: www.onclive.com/view/dr-nats...
I was the "Stop watching Shrek in your head!" kid but with tnbc and the original Frankenweenie
November 5, 2026 at 3:19 PM
I was the "Stop watching Shrek in your head!" kid but with tnbc and the original Frankenweenie
And to:
· the late Dr. Juliet Daniel, who researched aggressive and difficult to treat triple negative breast cancers (TNBC), which are most prevalent in young Black women.
Higher mortality rates of breast cancer in Black women in Canada means every health authority must collect race-based data.
· the late Dr. Juliet Daniel, who researched aggressive and difficult to treat triple negative breast cancers (TNBC), which are most prevalent in young Black women.
Higher mortality rates of breast cancer in Black women in Canada means every health authority must collect race-based data.
November 7, 2026 at 4:32 PM
And to:
· the late Dr. Juliet Daniel, who researched aggressive and difficult to treat triple negative breast cancers (TNBC), which are most prevalent in young Black women.
Higher mortality rates of breast cancer in Black women in Canada means every health authority must collect race-based data.
· the late Dr. Juliet Daniel, who researched aggressive and difficult to treat triple negative breast cancers (TNBC), which are most prevalent in young Black women.
Higher mortality rates of breast cancer in Black women in Canada means every health authority must collect race-based data.
The addition of invikafusp alfa to sacituzumab govitecan produced preliminary antitumor activity with no new safety signals in pretreated TNBC or HR+/HER2– breast cancer in the phase 1b/2 STARt-002 trial
Dive into the @sitcancer.bsky.social #SITC26 data here: www.onclive.com/view/invikaf...
Dive into the @sitcancer.bsky.social #SITC26 data here: www.onclive.com/view/invikaf...
November 8, 2026 at 6:27 PM
The addition of invikafusp alfa to sacituzumab govitecan produced preliminary antitumor activity with no new safety signals in pretreated TNBC or HR+/HER2– breast cancer in the phase 1b/2 STARt-002 trial
Dive into the @sitcancer.bsky.social #SITC26 data here: www.onclive.com/view/invikaf...
Dive into the @sitcancer.bsky.social #SITC26 data here: www.onclive.com/view/invikaf...
Hear from Ana Garrido-Castro, MD, and Filipa Lynce, MD, on recent treatment developments and research in metastatic #TNBC. This session is part of the 2026–2027 EMBRACE #MetastaticBreastCancer Forum Series and includes a Q&A moderated by Sahara Baral.
youtu.be/j17nMx4Uk-0?...
youtu.be/j17nMx4Uk-0?...
Updates in Triple Negative MBC | 2026-2027 Metastatic Breast Cancer Forum Series
YouTube video by Dana-Farber Cancer Institute
youtu.be
November 11, 2026 at 2:11 PM
Hear from Ana Garrido-Castro, MD, and Filipa Lynce, MD, on recent treatment developments and research in metastatic #TNBC. This session is part of the 2026–2027 EMBRACE #MetastaticBreastCancer Forum Series and includes a Q&A moderated by Sahara Baral.
youtu.be/j17nMx4Uk-0?...
youtu.be/j17nMx4Uk-0?...
RRIDs were included in this in Oncology Research paper. RRIDs improve reproducibility in scientific research. #OpenResearch #reproducibility #methodsmatter
Honokiol Suppresses Stemness and Sensitizes Triple-Negative Breast Cancer to Chemotherapy via YAP/TAZ-TEAD Inhibition
Objectives: As an aggressive subtype of breast cancer, triple-negative breast cancer (TNBC) is constrained by the limited availability of effective treatments and the absence of well-validated therapeutic targets. This study ... | Find, read and cite all the research you need on Tech Science Press
doi.org
November 9, 2026 at 8:00 AM
RRIDs were included in this in Oncology Research paper. RRIDs improve reproducibility in scientific research. #OpenResearch #reproducibility #methodsmatter
5) And in patients: across two independent TNBC cohorts, a higher stem-like CD8⁺ T cell signature was associated with favourable outcome.
November 6, 2026 at 8:00 AM
5) And in patients: across two independent TNBC cohorts, a higher stem-like CD8⁺ T cell signature was associated with favourable outcome.
In the phase 2 #VIOLETTE trial, #ceralasertib plus #olaparib improved ORR in patients without HRR mutations, but did not significantly improve PFS. #TNBC #Oncology #BreastOnc
Read more:
www.docwirenews.com/post/combina...
Read more:
www.docwirenews.com/post/combina...
November 6, 2026 at 2:29 AM
In the phase 2 #VIOLETTE trial, #ceralasertib plus #olaparib improved ORR in patients without HRR mutations, but did not significantly improve PFS. #TNBC #Oncology #BreastOnc
Read more:
www.docwirenews.com/post/combina...
Read more:
www.docwirenews.com/post/combina...
For people diagnosed with #TNBC, treatment can be complex and often involves multiple approaches.
Depending on the stage and specific characteristics of your cancer, here’s what to know about the different treatments your doctor may recommend: https://bit.ly/TNBCawareness
#breastcancer
Depending on the stage and specific characteristics of your cancer, here’s what to know about the different treatments your doctor may recommend: https://bit.ly/TNBCawareness
#breastcancer
November 6, 2026 at 10:43 PM
For people diagnosed with #TNBC, treatment can be complex and often involves multiple approaches.
Depending on the stage and specific characteristics of your cancer, here’s what to know about the different treatments your doctor may recommend: https://bit.ly/TNBCawareness
#breastcancer
Depending on the stage and specific characteristics of your cancer, here’s what to know about the different treatments your doctor may recommend: https://bit.ly/TNBCawareness
#breastcancer
Everyone deserves high-quality, affordable breast cancer care. But getting it isn't always easy.
Explore resources that can help: https://bit.ly/4kxzaz4
#breastcancer #breastcancersurvivor #tnbc #metavivor
Explore resources that can help: https://bit.ly/4kxzaz4
#breastcancer #breastcancersurvivor #tnbc #metavivor
November 5, 2026 at 5:04 PM
Everyone deserves high-quality, affordable breast cancer care. But getting it isn't always easy.
Explore resources that can help: https://bit.ly/4kxzaz4
#breastcancer #breastcancersurvivor #tnbc #metavivor
Explore resources that can help: https://bit.ly/4kxzaz4
#breastcancer #breastcancersurvivor #tnbc #metavivor
Advanced platinum strategies for triple-negative breast cancer
Advanced platinum strategies for triple-negative breast cancer
Triple-negative breast cancer (TNBC) is an aggressive cancer subtype with limited treatment options. Platinum chemotherapy is incorporated into several therapeutic strategies, but its clinical benefit is constrained by resistance, toxicity, and suboptimal patient stratification. Platinum-induced DNA crosslinking remains the principal mechanism underlying antitumor activity. Recent studies indicate that Pt(IV) prodrugs, multifunctional agents, subcellularly targeted complexes, and tumor-responsive delivery systems can extend platinum pharmacology beyond conventional cytotoxicity. In parallel, studies have revealed emerging vulnerabilities, including homologous recombination deficiency, immunogenic cell death, ferroptosis, and DNA damage response dependencies, that provide new opportunities to enhance efficacy and overcome resistance. Advanced translational models and biomarker-guided stratification may help translate these opportunities into more precise therapeutic strategies. In this article, we review these developments and discuss their implications for advanced platinum therapies in TNBC.
dlvr.it
November 6, 2026 at 12:42 PM
Advanced platinum strategies for triple-negative breast cancer
Remember the failed older kids experiment of 2009? Nelvana was carrying that entire operation with all three shows (Being Ian, Class of the Titans, Spliced).
Surely NBCU could have supplied some reruns of The Mummy or 1999 Woody or something from TNBC or ANYTHING?
Surely NBCU could have supplied some reruns of The Mummy or 1999 Woody or something from TNBC or ANYTHING?
November 3, 2026 at 4:19 AM
Remember the failed older kids experiment of 2009? Nelvana was carrying that entire operation with all three shows (Being Ian, Class of the Titans, Spliced).
Surely NBCU could have supplied some reruns of The Mummy or 1999 Woody or something from TNBC or ANYTHING?
Surely NBCU could have supplied some reruns of The Mummy or 1999 Woody or something from TNBC or ANYTHING?